In the early stages of breast cancer, STAT5A has been shown to promote malignant transformation and enhance tumor growth, whereas in established breast cancer, STAT5A is involved in maintaining the differentiation of mammary epithelium [41]. Here, STAT5A is linked to breast carcinoma.